Odyssey Health Inc. (OTCQB: ODYY) is a medical company with a focus in the area of life-saving medical solutions. Odyssey's corporate mission is to create, acquire and develop distinct assets, intellectual property, and exceptional technologies that provide meaningful medical solutions. The company is focused on areas that have an identified technological advantage, provide superior clinical utility, and have a substantial market opportunity. For more information, visit the company's website at www.odysseyhealthinc.com
Company profile
Ticker
ODYY
Exchange
Website
CEO
Joseph Michael Redmond
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
Odyssey Group International, Inc.
SEC CIK
ODYY stock data
Latest filings (excl ownership)
10-Q
2024 Q2
Quarterly report
22 Mar 24
NT 10-Q
Notice of late quarterly filing
18 Mar 24
S-8
Registration of securities for employees
5 Jan 24
S-8
Registration of securities for employees
5 Jan 24
8-K
Entry into a Material Definitive Agreement
5 Jan 24
8-A12G
Registration of securities
5 Jan 24
8-K
Completion of Acquisition or Disposition of Assets
29 Dec 23
10-Q
2024 Q1
Quarterly report
15 Dec 23
8-K
Regulation FD Disclosure
13 Dec 23
8-K
Submission of Matters to a Vote of Security Holders
7 Dec 23
Latest ownership filings
Financial summary
Quarter (USD) | Oct 23 | Jul 23 | Apr 23 | Jan 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Jul 23 | Jul 22 | Jul 21 | Jul 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 197.88 k | 197.88 k | 197.88 k | 197.88 k | 197.88 k | 197.88 k |
Cash burn (monthly) | (no burn) | (no burn) | 282.41 k | 340.29 k | 19.97 k | 94.17 k |
Cash used (since last report) | n/a | n/a | 1.66 mm | 2.00 mm | 117.20 k | 552.68 k |
Cash remaining | n/a | n/a | -1.46 mm | -1.80 mm | 80.69 k | -354.80 k |
Runway (months of cash) | n/a | n/a | -5.2 | -5.3 | 4.0 | -3.8 |
Institutional ownership, Q1 2023
13F holders | Current |
---|---|
Total holders | 0 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0.00 |
Total shares | 0.00 |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
16 Jan 24 | Gregory W Gironda | Stock Option Common Stock | Grant | Acquire A | No | No | 0.085 | 37,500 | 3.19 k | 37,500 |
16 Jan 24 | Erik Emerson | Stock Option Common Stock | Grant | Acquire A | No | No | 0.085 | 37,500 | 3.19 k | 37,500 |
10 Jan 24 | John P Gandolfo | ODYY - Common Stock | Grant | Acquire A | No | No | 0.09 | 1,500,000 | 135.00 k | 1,738,792 |
10 Jan 24 | John P Gandolfo | RSU ODYY Common Stock | Sale back to company | Dispose D | No | No | 0.09 | 1,500,000 | 135.00 k | 0 |
29 Dec 23 | Ricky Richardson | Stock Option Common Stock | Grant | Acquire A | No | No | 0 | 250,000 | 0.00 | 250,000 |
29 Dec 23 | Erik Emerson | Stock Option Common Stock | Grant | Acquire A | No | No | 0 | 200,000 | 0.00 | 200,000 |